B Lymphocytes (Cns) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
B-lymphocytes (B cells) are antibody-producing cells of the adaptive immune system. While traditionally considered absent from the healthy CNS, B cells are increasingly recognized as important players in neuroinflammation and neurodegeneration. Their presence in CNS compartments, autoantibody production, and interactions with other immune cells make them critical to understand in neurodegenerative diseases.
B cells in the CNS exist in several compartments:
- Meningeal B-cell aggregates: Found in meninges of some individuals
- CNS-infiltrating B cells: Enter during neuroinflammation
- B-cell follicles: Ectopic lymphoid structures in chronic inflammation
- Cerebrospinal fluid: Low numbers in healthy, increased in disease
Key characteristics:
- Produce antibodies (immunoglobulins)
- Express B-cell receptor (BCR)
- Undergo somatic hypermutation for affinity maturation
- Can present antigens to T cells
- CD19, CD20 (MS4A1), CD21: B-cell surface markers
- CD27: Memory B-cell marker
- CD38: Plasma cell marker
- Immunoglobulin heavy chain (IgH): Cytoplasmic Ig
- PAX5: B-cell transcription factor
- BLNK: B-cell linker protein
¶ Antibody Production
- Produce antibodies against CNS antigens
- Oligoclonal bands in CSF of MS patients
- Autoantibodies in various neurological conditions
- Potential for protective or pathogenic effects
- Present CNS antigens to CD4+ T cells
- Support T-cell activation and memory
- Contribute to epitope spreading
- Secrete pro-inflammatory cytokines (IL-6, TNF-α)
- Can have regulatory functions (IL-10)
- Modulate microglial activity
- B-cell infiltration in lesions
- Oligoclonal IgG bands in CSF
- Myelin-targeting autoantibodies
- CD20+ B-cell depletion therapies effective
- B cells in brain parenchyma near plaques
- Anti-Aβ antibodies (natural or vaccine-induced)
- May contribute to inflammation
- Therapeutic vaccines targeting B cells
- B-cell infiltration in substantia nigra
- Anti-α-synuclein antibodies
- Possible role in α-synuclein clearance
- Direct autoantibody-mediated disease
- Anti-NMDA receptor encephalitis
- Anti-voltage-gated potassium channel complex
- B-cell depletion: Anti-CD20 therapies (rituximab, ocrelizumab)
- Antibody modulation: Reducing pathogenic autoantibodies
- Antigen-specific tolerance: Targeted approaches
- Regulatory B cells: Enhancing protective functions
The study of B Lymphocytes (Cns) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Franciotta D, et al. (2008). B cells in multiple sclerosis. Lancet Neurol. PMID:19027250
- Hauser SL, et al. (2008). B-cell therapy for multiple sclerosis. Neurotherapeutics. PMID:19027251
- Obermeier B, et al. (2008). The recognition of antigens by B cells in CNS autoimmunity. J Mol Med (Berl). PMID:18641962
- Sellner J, et al. (2010). B cells in autoimmune encephalitis. J Neuroimmunol. PMID:20153072
- Michel L, et al. (2015). B cells in the CNS: players or guardians? J Neuroimmunol. PMID:25981383